Mary J.C. Hendrix, PhD, revealed a variance in signaling pathways in embryonic stem cells and metastatic melanoma cells that may impact new therapeutic strategies in cancer.
Browsing: Disease Discoveries
A study analyzed data from 82,000 women to see how stressful life events and social strain affect future development of coronary heart disease and stroke.
Northwestern Medicine scientists have discovered a novel cause of glaucoma in an animal model, and related to their findings, are now developing an eye drop aimed at curing the disease.
Northwestern Medicine scientists identified a previously unknown signaling pathway that enhances tumor growth in glioblastomas and head and neck cancers. The proteins in the pathway could be targeted in the treatment of human cancers.
Northwestern Medicine scientists have proven an old therapeutic focus for Huntington’s disease wrong, and they propose a new one in its place.
Northwestern Medicine scientists have expanded the understanding of how myelodysplastic syndromes develop.
Depleting an enzyme called GM3 synthase with gene therapy may help diabetics heal wounds faster.
Navdeep Chandel, PhD, David W. Cugell Distinguished Professor in Medicine-Pulmonary and Cell and Molecular Biology, focuses on the role of metabolism and signaling in disease.
Prostate cancer cells producing too much PIM1 are particularly sensitive to the inhibition of a protein called polo-like kinase (PLK1).
Northwestern Medicine scientists demonstrate that exposure to air pollution causes a stress response characterized by elevation in the level of the stress hormone adrenaline.